Key result
The first COVID-19 peak shows no excess all-cause mortality among CIED patients versus prior years.
Why the study?
The COVID-19 pandemic caused nationwide excess mortality in the Netherlands, and chronic heart disease patients are at risk for a complicated course.
Does the first peak of the COVID-19 pandemic increase all-cause mortality in adult CIED patients compared to previous years?
Cohort (n=9,556)
No
Does the first peak of the COVID-19 pandemic increase all-cause mortality in adult CIED patients compared to previous years?
The first peak of the COVID-19 pandemic did not result in excess all-cause mortality among high-risk CIED patients in the Leiden area, possibly due to strict adherence to preventive measures.
No excess mortality in CIED patients during early lockdown warrants continued vigilance; leaves open whether remote monitoring and precautions mitigated risk in this group.
In the Netherlands, the coronavirus disease 2019 (COVID‑19) pandemic has resulted in excess mortality nationwide. Chronic heart disease patients are at risk for a complicated COVID‑19 course. The current study investigates all-cause mortality among cardiac implantable electronic device (CIED) patients during the first peak of the pandemic and compares the data to the statistics for the corresponding period in the two previous years. Data of adult CIED patients undergoing follow-up at the Leiden University Medical Centre were analysed. All-cause mortality between 1 March and 31 May 2020 was evaluated and compared to the data for the same period in 2019 and 2018. At the beginning of the first peak of the pandemic, 3,171 CIED patients (median age 70 years; 68% male; 41% ischaemic aetiology) were alive. Baseline characteristics of the 2019 (n = 3,216) and 2018 (n = 3,169) cohorts were comparable. All-cause mortality during the peak of the pandemic was 1.4% compared to 1.6% and 1.4% in the same period in 2019 and 2018, respectively (p = 0.84). During the first peak of the COVID‑19 pandemic, there was no substantial excess mortality among CIED patients in the Leiden area, despite the fact that this is group at high risk for a complicated course of a COVID‑19 infection. Strict adherence to the preventive measures may have prevented substantial excess mortality in these vulnerable patients.
No takes yet. Share an insight, caveat, or question.
A 2022 study conducted a cohort in Cardiac implantable electronic device (CIED) patients (n=9,556). First peak of the COVID-19 pandemic (lockdown period) vs. Corresponding period in 2019 and 2018 was evaluated on All-cause mortality (p=0.84). During the first peak of the COVID-19 pandemic, all-cause mortality among CIED patients was 1.4%, showing no substantial excess mortality compared to 1.6% and 1.4% in the same periods in 2019 and 2018 (p=0.84).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: